Abstract:Aim Catechol-O-methyltransferase (COMT) gene variants may be involved in the pathogenesis of psychotic symptoms, and associated especially with negative symptom in schizophrenia, but their roles in cognitive function and treatment response remain unclear. The aim of this study was to explore the association between COMT gene polymorphisms, clinical symptoms (including cognitive function), and treatment response to antipsychotic medications in patients with schizophrenia. Patients and methods A total of 200 Han Chinese inpatients with schizophrenia were recruited in accordance with Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). In total, 96 of them completed assessments at baseline and after 8 weeks of antipsychotic treatment. Clinical symptoms were assessed using the Positive And Negative Syndrome Scale (PANSS), and cognitive function was evaluated using the Verbal Fluency Test, Trail Making Test A-B, Stroop Color-Word Test, and Wisconsin Card Sorting Test. Two single nucleotide polymorphisms, rs4680 and rs165599, on the COMT gene were genotyped. Results At baseline, we found no significant genotypic association between rs4680 and clinical symptoms or cognitive function. After 8 weeks of antipsychotic treatment, compared with patients with GG genotype, patients with AA/AG genotypes at rs4680 showed significantly higher scores on PANSS total, both at baseline and at the end of 8 weeks, especially in negative and general psychopathology symptoms. Patients with GG at rs165599 scored significantly higher on the Stroop test, suggesting better cognitive performance after 8 weeks of treatment. No significant association was found between rs165599 genotype and psychiatric symptoms as assessed by the PANSS and cognitive function tests at baseline. Conclusion Our findings suggest that the COMT gene polymorphisms may influence the response to antipsychotic treatment in Han Chinese patients with schizophrenia. (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.

Association Between Catechol-O-methyltransferase Genetic Variation and Functional Connectivity in Patients with First-Episode Schizophrenia

Genetic Contribution of Catechol-O-methyltransferase in Dorsolateral Prefrontal Cortex Functional Changes in the First Episode Schizophrenia

Genetic Polymorphism in Catechol‐o‐methyltransferase Associated with the Functional Connectivity of Frontostriatal Circuits in First Episode Schizophrenia Patients

COMT, 5-HTR2A, and SLC6A4 Mrna Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association with Treatment Outcomes

Morphological Changes in Gray Matter Volume Correlate with Catechol-O-methyl Transferase Gene Val158Met Polymorphism in First-Episode Treatment-Naïve Patients with Schizophrenia

Association Between Function and Structure of the Triple Network and Catechol-O-methyltransferase Val158met Polymorphism in the First Episode Schizophrenia.

Genetic Study of Neurocognitive Function in First-Episode Schizophrenia

The Catechol-O-methyltransferase Val158Met Polymorphism Modulates the Intrinsic Functional Network Centrality of the Parahippocampal Cortex in Healthy Subjects

Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions

Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortex

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression.

Association of Catechol-O-methyltransferase Val(108/158) Met Genetic Polymorphism with Schizophrenia, P50 Sensory Gating, and Negative Symptoms in a Chinese Population.

Association between COMT gene polymorphisms, clinical symptoms, and cognitive functions in Han Chinese patients with schizophrenia.

Associations between catechol O-methyltransferase genotypes and gene expression in human dorsolateral prefrontal cortex.

Catechol-O-methyltransferase Genotype Differentially Contributes to the Flexibility and Stability of Cognitive Sets in Patients with Psychotic Disorders and Their First-Degree Relatives.

Association Analysis of the Catechol‐o‐methyltransferase /methylenetetrahydrofolate Reductase Genes and Cognition in Late‐onset Depression

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Further evidence of transmission disequilibrium of the catechol-O-methyl transferase (COMT) gene in schizophrenia in a Chinese population

Interaction of Catechol‐O‐methyltransferase Val158Met Polymorphism and Sex Influences Association of Parietal Intrinsic Functional Connectivity and Immediate Verbal Memory

The inconsistent mediating effect of catechol O methyl transferase Val158Met polymorphism on the sex difference of cognitive impairment in schizophrenia patients

Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: an Updated Meta-Analysis.